In summary, these data show the potential of CYTOR exon 2 RNA to improve key disease hallmarks of DMD, including calcium homeostasis, mitochondrial function, pro‐inflammatory cytokine release, and muscle cell viability. The gene discussed is CYTOR; the disease is Duchenne muscular dystrophy.